Results 81 to 90 of about 2,776 (190)

Molecular Diagnosis in a Specialised Neurogenetic Clinic With Access to Whole‐Genome Sequencing

open access: yesActa Neurologica Scandinavica, Volume 2026, Issue 1, 2026.
Background Rare diseases, collectively affecting 1 in 17 people in the United Kingdom and Ireland, require coordinated care. Specialised multidisciplinary clinics offer a streamlined approach for diagnosis and management of rare neurogenetic disorders.
Patrick B. Moloney   +2 more
wiley   +1 more source

UCSF segmental schwannomatosis #2, tumor a, SOX10 immunostain

open access: yes, 2023
SOX10 immunostained section from tumor a of UCSF segmental schwannomatosis patient #2 with somatic mosaic SOX10 indel mutation.
David Solomon (4497931)
core   +1 more source

Schwannomatosis [PDF]

open access: yesNeurology, 2008
Alexey, Surov   +2 more
openaire   +2 more sources

Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis

open access: yes, 2015
OBJECTIVES: We aimed to determine the proportion of individuals in our schwannomatosis cohort whose disease is associated with an LZTR1 mutation. METHODS: We used exome sequencing, Sanger sequencing, and copy number analysis to screen 65 unrelated ...
Daly, Sarah   +19 more
core   +1 more source

The WHO Classification of Genetic Tumour Syndromes: Considerations for histopathology

open access: yes
Histopathology, Volume 88, Issue 7, Page 1291-1294, June 2026.
Ian A Cree   +18 more
wiley   +1 more source

NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study

open access: yesJournal of Medical Genetics
Objectives New diagnostic criteria for NF2-related schwannomatosis (NF2) were published in 2022. An updated UK prevalence was generated in accordance with these, with an emphasis on the rate of de novo NF2 (a 50% frequency is widely quoted in genetic counselling).
Claire Forde   +22 more
openaire   +4 more sources

sj-docx-1-ctj-10.1177_17407745231201345 – Supplemental material for Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration

open access: yes, 2023
Supplemental material, sj-docx-1-ctj-10.1177_17407745231201345 for Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS ...
Scott R Plotkin (16019131)   +3 more
core   +1 more source

UCSF segmental schwannomatosis #2, tumor a, CD34 immunostain

open access: yes, 2023
CD34 immunostained section from tumor a of UCSF segmental schwannomatosis patient #2 with somatic mosaic SOX10 indel mutation.
David Solomon (4497931)
core   +1 more source

18F-FDG PET/CT revealed sporadic schwannomatosis involving the lumbar spinal canal and both lower limbs: a case report

open access: yesFrontiers in Medicine
Schwannomatosis is a rare autosomal dominant hereditary syndrome disease characterized by multiple schwannomas throughout the body, without bilateral vestibular schwannoma or dermal schwannoma.
Xiaotian Li   +4 more
doaj   +1 more source

UCSF segmental schwannomatosis #2, tumor b, H&E

open access: yes, 2023
H&E stained section from tumor b of UCSF segmental schwannomatosis patient #2 with somatic mosaic SOX10 indel mutation.
David Solomon (4497931)
core   +1 more source

Home - About - Disclaimer - Privacy